TNFRSF4 and colitis: Given that OX40 expression has been shown to be increased in lamina propria lymphocytes of inflamed colon and that OX40L expression was increased in endothelium from inflamed colon (Souza et al., 1999), the therapeutic potential of targeting the OX40 pathway was tested in various mouse models of colitis.